Nalaganje...

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis

AIMS: To investigate the overall incidence and risk of hypertension in cancer patients who receive axitinib and compare the differences in incidences between axitinib and the other four approved vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs). METHODS: Several d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Qi, Wei-Xiang, He, Ai-Na, Shen, Zan, Yao, Yang
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769663/
https://ncbi.nlm.nih.gov/pubmed/23617405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12149
Oznake: Označite
Brez oznak, prvi označite!